Cited by 776Atrial Fibrillation Management and OutcomesCardiac Health and Mental HealthHeart Failure Treatment and Management

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial

Abed, Hany S., Wittert, Gary A., Leong, Darryl P., Shirazi, Masoumeh G., Bahrami, Bobak, Middeldorp, Melissa E., Lorimer, Michelle F., Lau, Dennis H., Antic, Nicholas A., Brooks, Anthony G., Abhayaratna, Walter P., Kalman, Jonathan M., Sanders, Prashanthan·2013·JAMA

DOI 10.1001/jama.2013.280521

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Obesity is a risk factor for atrial fibrillation. Whether weight reduction and cardiometabolic risk factor management can reduce the burden of atrial fibrillation is not known. OBJECTIVE: To determine the effect of weight reduction and management of cardiometabolic risk factors on atrial fibrillation burden and cardiac structure. DESIGN, SETTING, AND PATIENTS: Single-center, partially blinded, randomized controlled study conducted between June 2010 and December 2011 in Adelaide, Australia, among overweight and obese ambulatory patients (N = 150) with symptomatic atrial fibrillation. Patients underwent a median of 15 months of follow-up. INTERVENTIONS: Patients were randomized to weight management (intervention) or general lifestyle advice (control). Both groups underwent intensive management of cardiometabolic risk factors. MAIN OUTCOMES AND MEASURES: The primary outcomes were Atrial Fibrillation Severity Scale scores: symptom burden and symptom severity. Scores were measured every 3 months from baseline to 15 months. Secondary outcomes performed at baseline and 12 months were total atrial fibrillation episodes and cumulative duration measured by 7-day Holter, echocardiographic left atrial area, and interventricular septal thickness. RESULTS: Of 248 patients screened, 150 were randomized (75 per group) and underwent follow-up. The intervention group showed a significantly greater reduction, compared with the control group, in weight (14.3 and 3.6 kg, respectively; P < .001) and in atrial fibrillation symptom burden scores (11.8 and 2.6 points, P < .001), symptom severity scores (8.4 and 1.7 points, P < .001), number of episodes (2.5 and no change, P = .01), and cumulative duration (692-minute decline and 419-minute increase, P = .002). Additionally, there was a reduction in interventricular septal thickness in the intervention and control groups (1.1 and 0.6 mm, P = .02) and left atrial area (3.5 and 1.9 cm2, P = .02). CONCLUSIONS AND RELEVANCE: In this study, weight reduction with intensive risk factor management resulted in a reduction in atrial fibrillation symptom burden and severity and in beneficial cardiac remodeling. These findings support therapy directed at weight and risk factors in the management of atrial fibrillation. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12610000497000.

Integrity signals

Registry

Crossref · 10.1001/jama.2013.280521

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research
(1999) · Sleep · doi:10.1093/sleep/22.5.667 · Cited by 5,147
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.
McNicholas, W. T., Strohl, K. P., White, D. P., Levy, P. A., Schmidt, W., Wheatley, J. R., Redline, S. S., Carley, D. W., Buysse, D. J., Young, T. B., et al. (1999) · PubMed · Cited by 3,665
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033

Show all 52 references

Sorted by citations

Items 701–775 of 775

Cardiovascular Complications After Bariatric and Metabolic Surgery
Adil, M. T., Askari, A., & Mahawar, K. K. (2021) · Springer eBooks · doi:10.1007/978-981-33-4702-1_12
Wpływ otyłości na skuteczność kardiowersji elektrycznej u pacjentów z przetrwałym migotaniem przedsionków
Cichoń, M., Mizia‐Szubryt, M., Owczarek, A. J., Michalik, R., & Mizia‐Stec, K. (2021) · Folia Cardiologica · doi:10.5603/fc.a2021.0031
Effect of Obesity on Cardiovascular System: Literature Review
Sneineh, M. A. (2021) · Open access journal of clinical surgery · doi:10.51931/oajcs.2021.02.000021
Kan je bestaande voorkamerfibrillatie verminderen met sport?
Finoulst, M., Vankrunkelsven, P., & Claessen, G. (2021) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.77.21.174
Diabetes Update 2014 – das spannendste Diabetes-Update aller Zeiten
Scherbaum, W. A. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1190-4
Впервые диагностированная фибрилляция предсердий и ожирение у людей пожилого возраста в терапевтической практике
Riabaia, I., Сердечная, Е. В., & Владимировна, Ю. С. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.10.22
Care of the patient with cardiac arrhythmias
Lee, G., Fålun, N., Angus, N. J., Hendriks, J., Norekvål, T. M., Berg, S. K., & Fitzsimons, D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849315.003.0007
Prevention of Atrial Fibrillation
Kornej, J., & Benjamin, E. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_23
Bibliographie
(2018) · Mardaga eBooks · doi:10.3917/mard.scave.2018.01.0289
Review of the guidelines of the European society of cardiology 2020 for the diagnosis and treatment of atrial fibrillation
Mihajlovic, M., Šimić, J., Marinković, M. M., Mujović, N. M., Prostran, M. S., & Potpara, T. (2022) · Galenika Medical Journal · doi:10.5937/galmed2201093m
Atrial Fibrillation
Haı̈ssaguerre, M., Glover, B. M., & Brugada, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-74319-2_8
Atrial Fibrillation
Glover, B. M., & Brugada, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-40818-7_8
Perdre du poids modifie le pronostic de la FA
(2014) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(14)72398-6
The Effect of Anthropometric Measurements on the Incidence of Atrial Fibrillation in Patients With Acute Myocardial Infarction
Oskay, T., Türker, Y., Oskay, A., Arı, H., & Özaydın, M. (2022) · Cureus · doi:10.7759/cureus.25356
Rhythmusmanagement bei Vorhofflimmern
Metzner, A., Gunawardene, M., & Willems, S. (2022) · Nervenheilkunde · doi:10.1055/a-1822-1085
Role of Insulin Resistance in the Development of Atrial Fibrillation
YİĞİT, E., & Erciyes, D. (2022) · Namık Kemal Tıp Dergisi · doi:10.4274/nkmj.galenos.2022.31932 · Cited by 1
Prevalence and Impact of Poorly Controlled Modifiable Risk Factors Among Patients Undergoing Atrial Fibrillation AblationPreprint
Stout, K. M., Almerstani, M., Adomako, R., Shin, D., Tandon, H. K., Schleifer, J. W., Payne, J., Easley, A., Khan, F., Windle, J. R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2183474/v1
Obesidad y fibrilación auricular
Díaz-Cano, S. M., Duque-Ramírez, M., Lopera-Mejía, L., & Palacio-Uribe, J. I. (2022) · Revista Colombiana de Cardiología · doi:10.24875/rccar.21000091
Cognitive disorders in patients with atrial fibrillation
Yepanchintseva, O. A., Solonovych, A. S., & Solonovych, O. S. (2023) · Cardiac Surgery and Interventional Cardiology · doi:10.31928/2305-3127-2023.1-2.1521
Case 32-2023: A 62-Year-Old Woman with Recurrent Hemorrhagic Pericardial Effusion
Yucel, E., Patel, N., Crousillat, D. R., Baliyan, V., Jassar, A. S., Palacios, I. F., Inglessis, I., & Smith, R. N. (2023) · New England Journal of Medicine · doi:10.1056/nejmcpc2115845
Atrial Fibrillation and Stroke
Rodríguez, J. E., & Sposato, L. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-43036-7_6
Identification of metabolic biomarkers in atrial fibrillation patients via the integrated application of proteomics and metabolomicsPreprint
Chao, X., Xu, Y.-J., Zhang, H., Xing, N., Shu, C., Chanda, F., Chaurembo, A. I., Zhang, H., Huang, J.-Y., Fu, L.-D., et al. (2024) · doi:10.22541/au.171118702.24019292/v1
Weight reduction interventions for the management of atrial fibrillation in overweight and obese people
Valli, H., Tindale, A., Butt, H., Beattie, C. J., Adasuriya, G., Warraich, M., Ahmad, M., Banerjee, A., Providencia, R. A., & Haldar, S. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014768
The emerging role of extracellular vesicle RNAs as mediators of cardiometabolic diseases: from pathophysiology to clinical applications
Limpitikul, W. B., García-Contreras, M., & Das, S. (2024) · Current Opinion in Physiology · doi:10.1016/j.cophys.2024.100764 · Cited by 1
Clinical Trials for Atrial Fibrillation—What Do We Know?
Kerr, N. P., Chew, D. S., & Wilton, S. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00023-6
Prediction models for personalized
Tohidinezhad, F. (2024) · doi:10.26481/dis.20250122ft
Epidemiology: Atrial Fibrillation, Stroke, and Anticoagulation
Pham, R., & Cakulev, I. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68441-8_1
The Therapeutic Impact of Genetic Evaluation in an Atrial Fibrillation Precision Medicine ClinicPreprint
Laws, J. L., Shabani, M., Williams, H. L., Grauherr, D. D., Kilbourne, W. M., Crawford, D. M., Ogunmola, I., Sun, L., Virk, Z. M., Cathey, B. M., et al. (2025) · medRxiv · doi:10.1101/2025.03.28.25324544
Cardiometabolic-Based Chronic Disease
Hernández-Sevillano, J., Babagoli, M. A., Mellacheruvu, P., & Mechanick, J. I. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_6
Time to Begin Again?
Steinberg, B. A. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.03.033
The Importance of Incorporating Lifestyle Modification Into AF Treatment Is Difficult to Measure
Parkash, R., & Piccini, J. P. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.065
Sham-Controlled Trials and the Future of Electrophysiology: Reflections on SHAM-PFA
Mhanna, M., Mandrola, J. M., & Olshansky, B. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.09.017
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIV
Kobe, E. A., Clare, R. M., Chiswell, K., Longenecker, C. T., Marsolo, K. A., Meissner, E. G., Okeke, N. L., Pettit, A. C., Morse, C. G., Gray, S., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102287
Racial and ethnic disparities in the management of risk factors in individuals with atrial fibrillation: A narrative review
D’Oro, A., D’Costa, Z. U., Tang, J., Min, S., Jackson, L. R., & Essien, U. R. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101361
Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation
Boidin, M., Buckley, B. J. R., Lip, G. Y. H., & Thijssen, D. H. J. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101362
Additional file 1 of Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol
Win, K. Z., Armstrong, M., Steeds, R. P., & Kalla, M. (2024) · Figshare · doi:10.6084/m9.figshare.25264281
Additional file 2 of Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol
Win, K. Z., Armstrong, M., Steeds, R. P., & Kalla, M. (2024) · Figshare · doi:10.6084/m9.figshare.25264414
Additional file 1 of Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: a systematic review and dose–response meta-analysis
Zhao, H., Li, X., Yu, P., Liu, M., Ma, J., Wang, J., Zhu, W., & Liu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26565321
Additional file 1 of Underweight is a major risk factor for atrial fibrillation in Asian people with type 2 diabetes mellitus
Hsu, J.-C., Yang, Y.-Y., Chuang, S.-L., Chung, Y.-W., Wang, C.-H., & Lin, L.-Y. (2021) · Figshare · doi:10.6084/m9.figshare.17079568
Rhythm Control and Risk Reduction: Evidence From a Narrative Review on Therapeutic Advances in Cardiac Arrhythmia Management
Sanyaolu, S. E., Ogundele, O. I., Ogbe, M. O., Nweke, O. J., Alao, H. O., Usman, F. A., Coker, M. U., Oludaisi, H. O., & Akinmeji, O. S. (2025) · Premier Journal of Cardiology · doi:10.70389/pjc.100014
Outcomes in Patients With Atrial Fibrillation Stratified by Body Mass Index and Heart Failure Status
Noubiap, J. J., Kaltenbach, L. A., Chiswell, K., Nyaga, U. F., Chung, M. K., Hendriks, J., Jackson, L. R., Russo, A. M., Volgman, A. S., Turchioe, M. R., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102531
Sex-specific impact of body mass index on recurrence of atrial fibrillation after catheter ablation
Özcan, C., Deshmukh, A., Aziz, Z. A., Mayer, M., Kassem, H. A., Treger, J. S., Yeshwant, S. C., Beaser, A. D., Upadhyay, G., Huang, H., et al. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.01.024
Effectiveness and safety of yoga-based interventions in the management of atrial fibrillation: a systematic review
Elamir, A. A. K. M., Adam, Y. A. M., Abdel-Rahman, I. M., Elnosh, H. A. A., Mohammad, M. A. A., Ahmed, O., Ahmed, R. A. O., Ahmed, A. A., Ahmed, R. A. A., & Farah, A. F. A. (2026) · Sport Sciences for Health · doi:10.1007/s11332-025-01641-1
Spatial Autocorrelation Dimension (Di) for the Characterisation of Atrial Fibrillatory Dynamics
Tiver, K. D., Dharmaprani, D., & Ganesan, A. (2026) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2024.06
Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study
Rosales-Rojas, A., Teis, A., Gil, P., Rossell, J., Pedraz-Petrozzi, B., Viladés, D., Sánchez‐Quesada, J. L., García‐Osuna, Á., Mauricio, D., Julve, J., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03105-3
Omic approach to atrial fibrillation
Puertas, R. D. (2017) · theses.fr (ABES) · doi:10.70675/dd1855ebz1421z42e4zb00czd5476f4de207
A Qualitative Investigation of Barriers, Facilitators, and Preferences Regarding a Cardiac Rehabilitation-Based Behavioral Weight Loss Program in Adults with Atrial Fibrillation and Obesity
Williamson, T. M., Campbell, T. S., Seidel, S., King‐Shier, K. M., Wilton, S. B., Tomfohr‐Madsen, L. M., Aggarwal, S., Arena, R. A., & Rouleau, C. R. (2026) · Behavioral Medicine · doi:10.1080/08964289.2026.2641456
Exercise, Ethnicity, and Quality of Life in Older Adults with Persistent Nonvalvular Atrial Fibrillation: A Multicenter Cross-Sectional Study
Xu, Y., Zhao, X., Zheng, X., Shi, S., Lv, F., Dong, R., & Liu, K. (2026) · Clinical Interventions in Aging · doi:10.2147/cia.s599331
Does Weight Loss Prevent Atrial Fibrillation?
Marcus, G. M. (2026) · JAMA · doi:10.1001/jama.2026.6094
Association Between Weight Change and the Risk of Atrial Fibrillation: Results from the Kailuan Cohort Study in China
Liu, H., Liu, Y., Chou, O. H. I., Tse, G., (388386), S. W., & Liu, T. (2026) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2026.0017
Integrated Genomic and Transcriptomic Analysis Reveals the Genetic Basis and Causal Association Between Obesity and Atrial Fibrillation
Wu, X., Xu, G., Wang, R., Cai, Q., Kang, J., Ruan, M., Ren, J., Li, Y., & Gong, L. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71016
Assessing the impact of combined nutritional and physical activity interventions for patients with atrial fibrillation who are overweight: a systematic review protocol
Murphy, D., Graby, J., Hirst, L., Rodrigues, J., Thompson, D., & Khavandi, A. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-119196
ATRIAL FIBRILLATION AND STROKE RISK: PREVENTION STRATEGIES AND PUBLIC HEALTH IMPLICATIONS
Ziemba-Furgała, N. M., Szwed, A., Borzęcka, K. A., Polewczak-Karp, E. M., Warzocha-Żurek, D. A., Andryszko, K., Soltys, A., Dymon, M., Krysa, P., & Wawrzonek, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5447
Effects of cardiac rehabilitation on atrial fibrillation recurrence, mortality, hospitalization, and exercise capacity: a systematic review and meta-analysis
Shen, T., Shi, C., Li, G. H., Jiang, Y., Li, D., Qian, L., Ma, C., Wang, G., Zheng, L., & Shen, Y. (2026) · PeerJ · doi:10.7717/peerj.21422 · Cited by 1
Metformin as an Upstream Substrate-Modifying Strategy for Atrial Fibrillation in Metabolic Dysfunction: Mechanistic Rationale and Clinical Evidence
Vempati, R., Gahona, C. C. T., Haddad, F. F., Manickavelan, H. V., Zakaria, F., Hanna, J., Sanusi, M., Bhatt, P., Haddad, R., Mohammed, F., et al. (2026) · Journal of Molecular Pathology · doi:10.3390/jmp7030025
Total care strategies in atrial fibrillation practice: Lifestyle intervention and risk factor management
Tokuda, M., Yamashita, S., Yokoyama, M., Tokutake, K., & Yamane, T. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.06.018
Heart-brain interaction and research progress following traumatic brain injury
Shen, D., Huang, R., Wang, L., Pang, Q., Li, M., & Wang, T. Z. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.018
A new approach to an old disease: Ageing, arrhythmogenic substrate and the role of risk‐factor modification in atrial fibrillation
Thakur, U., & Kalman, J. M. (2026) · Experimental Physiology · doi:10.1113/ep093597
Contemporary concepts in the onset and maintenance of atrial fibrillation: Mechanisms, substrates, and clinical implications
Ciaccio, E. J., Hsia, H. H., Talke, M., Schwartz, S. M., Garan, H., Yarmohammadi, H., Peters, N. S., Coromilas, J., & BIVIANO, A. B. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.017
Cardiometabolic and Endocrine Correlates of Left Atrial Scar in Patients Undergoing Atrial Fibrillation Ablation
Prakash, A., Patel, K., Ganesan, A. V., Patel, G., & Gandhi, D. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70374
Review of the Relationship Between Obstructive Sleep Apnea and Atrial Fibrillation
Blacker, M. J., Rodriguez, L. D. R., Shah, C. D., Frishman, W. H., Aronow, W. S., & Rojas, R. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001408
Body mass index, acute atrial fibrillation termination, and long-term recurrence after catheter ablation for persistent atrial fibrillation: Insights from a large contemporary cohort
Cui, N., Han, K., Shao, W., He, L., Fu, B., Peng, Y., Zhu, H., Jiang, C., Wang, W., Sang, C., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.08.001
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
Benjamin, E. J., Marcus, G. M., Hess, P. L., Addison, D., Akar, J. G., Brownell, N. K., Chyou, J. Y., Derington, C. G., Diekemper, R. L., Frankel, D. S., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.05.032
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures
Benjamin, E. J., Marcus, G. M., Hess, P. L., Addison, D., Akar, J. G., Brownell, N. K., Chyou, J. Y., Derington, C. G., Diekemper, R. L., Frankel, D. S., et al. (2026) · Circulation Population Health and Outcomes · doi:10.1161/hcq.0000000000000149
Strategies for preventing and reversing atrial cardiomyopathy: current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement
Zakeri, R., Camilli, M., D’Elia, E., Hulot, J., Iacoviello, M., Sisti, N., Țica, O., Tokmakova, M. P., den Eynde, J. V., Weerts, J., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag268
Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF)
Deshmukh, A., Shah, M. M., Kozlowski, P., Chakrabarti, A. K., Turin, A., Arps, K. E., Ghannam, M., Liang, J. J., Saeed, M., Cunnane, R. T., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.07.008
DUTCH weight control in atrial fibrillation study (DUTCH-WAIST)
Voorhout, L., Pisters, R., Huisman, M. V., Klok, E., Rutten, F. H., Geersing, G., Tieleman, R. G., Cornel, J. H., Schut, A., Tijssen, J. G. P., et al. (2026) · Netherlands Heart Journal · doi:10.1007/s12471-026-02074-2
Weight Loss in Older Adults With Persistent Atrial Fibrillation—Reply
Sclafani, M., Casadei, B., & Wijesurendra, R. S. (2026) · JAMA · doi:10.1001/jama.2026.14482
Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy
Jiang, X.-H., Wang, R.-Z., Sheng, Y.-W., & Liu, L. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1948993
Obesity, Metabolic Modulation, and Arrhythmias: From Adipose Tissue Dysfunction to a Modifiable Arrhythmogenic Substrate
Tiezzi, M., Valli, F., Mengozzi, A., Ferroni, L., Brasini, S., Capirossi, G., Gentileschi, P., & Tremoli, E. (2026) · Biomedicines · doi:10.3390/biomedicines14102269
Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation
Matteucci, A., Bonanni, M., Sgarra, L., Nesti, L., Mariani, M. V., Pierucci, N., Cersosimo, A., Pittorru, R., Nardi, F., & Colivicchi, F. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13100512
Obesity and Atrial Fibrillation: Weighing the Evidence
Ha, F. J., Tang, J. Y., Khanna, S., Brown, A. J., Kotschet, E., & Nerlekar, N. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15208101
2026 Asia Pacific Heart Rhythm Society ( APHRS ) Guidelines (Part IV ) on Comprehensive Lifestyle Risk Factor and Comorbidity Management in Atrial Fibrillation
Choi, E., Middeldorp, M. E., Ahn, H., Ariyaratnam, J., Elliott, A. D., Hung, C., Yu, H. T., Sharma, G., Wang, N., Yamaguchi, T., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70490
The influence of lifestyle on the occurrence and course of arrhythmias
Sidnyaev, V., Shvedov, I., Gerbig, N., Veryaskina, A., & Svishcheva, M. (2026) · Vrach · doi:10.29296/25877305-2026-09-16
Impact of obesity on procedural safety and 1-year outcomes after pulsed-field ablation for atrial fibrillation
Massoullié, G., Chaumont, C., Laredo, M., Pereira, B., Thomas, O., Maury, P., Defaye, P., Bovéda, S., Marijon, É., Escande, W., et al. (2026) · EP Europace · doi:10.1093/europace/euag288

Authors: Abed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., Abhayaratna, W. P., Kalman, J. M., & Sanders, P.
Affiliations: Royal Adelaide Hospital (AU)
The University of Adelaide (AU)
Repatriation General Hospital (AU)
Australian National University (AU)
The Royal Melbourne Hospital (AU)
ORCID: Wittert, Gary A.
Leong, Darryl P.
Bahrami, Bobak
Middeldorp, Melissa E.
Lorimer, Michelle F.
Lau, Dennis H.
Abhayaratna, Walter P.
Kalman, Jonathan M.
Sanders, Prashanthan
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2013-11-20
Volume: 310
Issue: 19
Pages: 2050
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2013.280521
OpenAlex: W1963940525
Cited by: 776
References: 52
Citations by year: 2026: 51 · 2025: 64 · 2024: 69 · 2023: 53 · 2022: 56 · 2021: 76 · 2020: 50 · 2019: 70 · 2018: 52 · 2017: 81 · 2016: 63 · 2015: 51 · 2014: 35 · 2013: 4
FWCI: 34.64
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Flinders Academic Commons (Flinders University) (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Flinders Academic Commons (Flinders University) (submittedVersion)
ANU Open Research (Australian National University) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: weight loss, obesity, cardiometabolic risk factors, symptom burden, symptom severity, cardiac remodeling, left atrial area, interventricular septum thickness, lifestyle intervention, overweight patients, Holter monitoring, cardiac structure, risk factor control, weight management, lifestyle advice
MeSH terms: Aged, Atrial Fibrillation, Diet, Reducing, Echocardiography, Fish Oils, Heart Atria, Humans, Life Style, Male, Middle Aged, Obesity, Risk Factors, Severity of Illness Index, Weight Loss, Treatment Outcome, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks